Assignee
EMCURE PHARMACEUTICALS LTD
IN·16 granted patents·8 pending applications·16 citations·filing 2003–2022
Top patents by PatentIndex Score
24 records- 0180US10583101B2Lipid formulations of carmustineEMCURE PHARMACEUTICALS LTD·Filed 2017·Granted Mar 10, 2020·2 cites·18 claims
- 0277US8030480B2Cost-effective process for preparation of manufacture of iron sucroseEMCURE PHARMACEUTICALS LTD·Filed 2005·Granted Oct 4, 2011·7 cites·18 claims
- 0366US6982349B1Process for producing atenolol of high optical purityEMCURE PHARMACEUTICALS LTD·Filed 2003·Granted Jan 3, 2006·6 cites·8 claims
- 0465US11865206B2Stable ready-to-use carmustine pharmaceutical compositionEMCURE PHARMACEUTICALS LTD·Filed 2022·Granted Jan 9, 2024·0 cites·10 claims
- 0565US9643914B2Fingolimod hydrochloride processEMCURE PHARMACEUTICALS LTD·Filed 2014·Granted May 9, 2017·1 cites·10 claims
- 0656US12427127B2Carmustine formulationEMCURE PHARMACEUTICALS LTD·Filed 2019·Granted Sep 30, 2025·0 cites·5 claims
- 0755US2023210793A1Method for rapid infusion of carmustineEMCURE PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0854US2021322304A1Stable ready-to-use carmustine pharmaceutical compositionEMCURE PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 0953US2021038543A1Kit for preparing injectable carmustine solutionsEMCURE PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1052US7858801B2Process for producing enantiomer of amlodipine in high optical purityEMCURE PHARMACEUTICALS LTD·Filed 2005·Granted Dec 28, 2010·0 cites·7 claims
- 1150US10278946B2Liquid formulation of cabazitaxelEMCURE PHARMACEUTICALS LTD·Filed 2018·Granted May 7, 2019·0 cites·4 claims
- 1250US9403809B2Synthesis of raltegravirEMCURE PHARMACEUTICALS LTD·Filed 2012·Granted Aug 2, 2016·0 cites·13 claims
- 1349US9475799B1Synthesis of RaltegravirEMCURE PHARMACEUTICALS LTD·Filed 2016·Granted Oct 25, 2016·0 cites·5 claims
- 1448US10508075B2Process for preparation of trientine dihydrochlorideEMCURE PHARMACEUTICALS LTD·Filed 2016·Granted Dec 17, 2019·0 cites·5 claims
- 1548US2020108010A1Kit for preparing injectable carmustine solutionsEMCURE PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 1645US10759738B2Process for preparation of isoproterenol hydrochlorideEMCURE PHARMACEUTICALS LTD·Filed 2018·Granted Sep 1, 2020·0 cites·10 claims
- 1744US9522924B1Pyridone derivatives as acid secretion inhibitors and process for preparation thereofEMCURE PHARMACEUTICALS LTD·Filed 2016·Granted Dec 20, 2016·0 cites·16 claims
- 1840US9447094B2Pyridone derivatives as acid secretion inhibitors and process for preparation thereofEMCURE PHARMACEUTICALS LTD·Filed 2015·Granted Sep 20, 2016·0 cites·16 claims
- 1937US9919993B2Process for preparation of acitrecinEMCURE PHARMACEUTICALS LTD·Filed 2015·Granted Mar 20, 2018·0 cites·7 claims
- 2037US2018311203A1Liquid formulation of cabazitaxelEMCURE PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 2136US10556851B2Process for preparation of prostacyclin derivativesEMCURE PHARMACEUTICALS LTD·Filed 2017·Granted Feb 11, 2020·0 cites·12 claims
- 2233US2019309014A1Process for preparation of icatibant acetateEMCURE PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 2332US2019269616A1Sterile parenteral suspensionsEMCURE PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 2428US2019031665A1Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancerEMCURE PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →